Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BNTC

Benitec Biopharma Inc

Jul 26 • 04:00PM ET

9.40

Dollar change +0.27
Percentage change 2.96	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VXF PINK IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-9.87	Insider Own	18.26%	Shs Outstand	2.72M	Perf Week	1.95%
Market Cap	25.57M	Forward P/E	-	EPS next Y	-1.86	Insider Trans	0.00%	Shs Float	2.23M	Perf Month	40.09%
Income	-21.69M	PEG	-	EPS next Q	-0.49	Inst Own	101.28%	Short Float	3.73%	Perf Quarter	35.45%
Sales	0.01M	P/S	2556.80	EPS this Y	63.03%	Inst Trans	-	Short Ratio	2.08	Perf Half Y	229.82%
Book/sh	4.22	P/B	2.23	EPS next Y	64.30%	ROA	-186.85%	Short Interest	0.08M	Perf Year	162.06%
Cash/sh	5.21	P/C	1.81	EPS next 5Y	-	ROE	-267.59%	52W Range	1.86 - 10.88	Perf YTD	191.02%
Dividend Est.	-	P/FCF	-	EPS past 5Y	66.41%	ROI	-187.61%	52W High	-13.60%	Beta	0.87
Dividend TTM	-	Quick Ratio	4.18	Sales past 5Y	-27.97%	Gross Margin	-4700.00%	52W Low	405.38%	ATR (14)	0.72
Dividend Ex-Date	-	Current Ratio	4.18	EPS Y/Y TTM	59.77%	Oper. Margin	-308571.43%	RSI (14)	56.79	Volatility	7.02% 8.37%
Employees	18	Debt/Eq	0.03	Sales Y/Y TTM	-89.71%	Profit Margin	-309885.71%	Recom	1.00	Target Price	19.67
Option/Short	No / Yes	LT Debt/Eq	0.01	EPS Q/Q	38.78%	Payout	-	Rel Volume	0.33	Prev Close	9.13
Sales Surprise	-	EPS Surprise	-110.26%	Sales Q/Q	-100.00%	Earnings	May 13 BMO	Avg Volume	39.93K	Price	9.40
SMA20	3.83%	SMA50	12.02%	SMA200	77.50%	Trades		Volume	13,317	Change	2.96%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-22-24	Initiated	Leerink Partners	Outperform	$13
Jun-13-24	Initiated	Piper Sandler	Overweight	$30
Oct-05-20	Downgrade	Ladenburg Thalmann	Buy → Neutral
Apr-20-20	Initiated	Ladenburg Thalmann	Buy	$14
Feb-26-16	Downgrade	Maxim Group	Buy → Hold
Dec-31-15	Reiterated	Maxim Group	Buy	$23 → $14
Sep-16-15	Reiterated	Maxim Group	Buy	$4 → $23

Jul-15-24 06:00AM	Benitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for First OPMD Subject Treated with Low-Dose BB-301 in Phase 1b/2a Study (GlobeNewswire) +7.71%
Jul-01-24 07:00AM	Benitec Biopharma Announces Appointment of Kishen Mehta to its Board of Directors (GlobeNewswire)
May-13-24 02:53PM	BNTC Stock Earnings: Benitec Biopharma Misses EPS for Q3 2024 (InvestorPlace) -12.22%
08:15AM	Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire)
May-01-24 08:00AM	Benitec Biopharma to Participate in the Citizens JMP Life Science Conference (GlobeNewswire) -6.51%
07:30AM	Loading…
Apr-18-24 07:30AM	Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study (GlobeNewswire) +42.08%
07:00AM	Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million (GlobeNewswire)
Apr-09-24 08:00AM	Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024 (GlobeNewswire)
Mar-24-24 07:55AM	11 Best ASX Stocks To Buy Now (Insider Monkey)
Feb-13-24 08:00AM	Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire)
Nov-30-23 07:00AM	Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy (GlobeNewswire)
Nov-17-23 08:00AM	Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-13-23 08:00AM	Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire)
Sep-21-23 08:00AM	Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational Update (GlobeNewswire)
Aug-21-23 09:02PM	Citadel Advisors LLC Acquires New Stake in Benitec Biopharma Inc (GuruFocus.com)
09:02PM	Loading…
Aug-18-23 09:02PM	JANUS HENDERSON GROUP PLC Acquires New Stake in Benitec Biopharma Inc (GuruFocus.com)
Aug-11-23 01:00PM	Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering (GlobeNewswire)
Aug-08-23 10:30PM	Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering (GlobeNewswire) +65.80%
Jul-25-23 01:00PM	Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023 (GlobeNewswire)
Jun-26-23 08:00AM	Benitec Biopharma Receives FDA Clearance of the IND for BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy (GlobeNewswire) +80.90%
May-15-23 08:00AM	Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire)
May-08-23 08:05AM	Benitec Biopharma to Present at the OPMD International Conference (GlobeNewswire)
08:00AM	Benitec Biopharma to Present at the JMP Securities Life Sciences Conference (GlobeNewswire)
Feb-13-23 08:00AM	Benitec Biopharma Releases Second Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire)
Jan-23-23 09:48AM	Benitec Biopharma Enrolls First OPMD Subject into the Clinical Development Program (GlobeNewswire) +9.08%
Nov-10-22 08:00AM	Benitec Biopharma Releases First Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire) +5.79%
Sep-16-22 08:42AM	Benitec Biopharma Inc. Announces Closing of $18 Million Underwritten Public Offering (GlobeNewswire) -15.43%
Sep-12-22 10:06PM	Benitec Biopharma Inc. Announces Pricing of $18 Million Underwritten Public Offering (GlobeNewswire) -6.63% -28.34%
Sep-02-22 08:00AM	Benitec Biopharma Releases Full Year 2022 Financial Results and Provides Operational Update (GlobeNewswire)
Jul-15-22 06:52AM	Having purchased US$827k worth of Benitec Biopharma Inc. (NASDAQ:BNTC) stock, the recent 11% pullback is not what insiders may have expected (Simply Wall St.) +7.00%
08:15AM	Loading…
May-16-22 08:15AM	Benitec Biopharma Releases Q3 2022 Financial Results (GlobeNewswire) -8.79%
Feb-14-22 08:00AM	Benitec Biopharma Discloses Q2 2022 Financial Results (PR Newswire)
Jan-18-22 12:53PM	/C O R R E C T I O N from Source -- Norra Metals Corp./ (PR Newswire) -6.64%
Jan-17-22 09:30AM	Norra Metals Announces Private Placement Financing (PR Newswire)
Nov-27-21 06:54AM	We're Keeping An Eye On Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Rate (Simply Wall St.)
Nov-15-21 08:00AM	Benitec Biopharma Discloses Q1 2022 Financial Results (PR Newswire)
Sep-20-21 08:00AM	Benitec Biopharma Provides Operational Update and Releases its 2021 Fiscal Year-End Financial Results (PR Newswire) -7.86%
Sep-13-21 03:58PM	Benitec Biopharma to present at H.C. Wainwright's 23rd Annual Global Investment Conference (PR Newswire)
Sep-08-21 08:10AM	Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial Design for 2022 (PR Newswire)
08:05AM	Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in Large Animals (PR Newswire)
08:00AM	Benitec Biopharma Provides Positive Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022 (PR Newswire)
May-31-21 01:54AM	Is Benitec Biopharma (NASDAQ:BNTC) In A Good Position To Invest In Growth? (Simply Wall St.)
Apr-27-21 09:55PM	Benitec Biopharma Increases Previously Announced Bought Deal Offering of Common Stock to $12.9 Million (PR Newswire) -20.62%
04:44PM	Benitec Biopharma Announces $7.5 Million Bought Deal Offering of Common Stock (PR Newswire)
Mar-23-21 12:18PM	5 Top Stock Gainers for Tuesday: Dolphin Entertainment, Benitec (TheStreet.com) +190.28%
07:24AM	Tuesdays Pre-Market: Heres What You Need To Know Before The Market Opens (SmarterAnalyst)
07:09AM	Benitec Shares Skyrocket as Morgan Stanley Takes Stake (TheStreet.com)
Feb-24-21 09:26AM	Benitec Biopharma's Gene Therapy For Rare Muscle Disorder Shows Encouraging Action In Animal Studies (Benzinga) +5.60%
08:29AM	Benitec Biopharma Announces Successful Results from the Interim Analysis of the BB-301 Pilot Dosing Study (PR Newswire)
Dec-07-20 02:33PM	Benitec Biopharma Announces 2020 Annual Stockholder Meeting (PR Newswire)
Dec-02-20 12:06AM	A Quick Analysis On Benitec Biopharma's (NASDAQ:BNTC) CEO Compensation (Simply Wall St.)
Oct-06-20 04:05PM	Benitec Biopharma Announces Closing of $11.5 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares (PR Newswire)
Oct-02-20 09:05AM	Benitec Biopharma Announces Pricing of $10.0 Million Public Offering (PR Newswire) -36.74%
Sep-23-20 04:54PM	Benitec Biopharma Provides Operational Update and Releases its 2020 Fiscal Year-End Financial Results (PR Newswire)
Sep-01-20 08:15AM	Benitec Biopharma to present at H.C. Wainwright's 22nd Annual Global Investment Conference (PR Newswire)
Jul-08-20 08:00AM	Benitec Biopharma Provides Update on BB-301 Tissue Transduction Study (PR Newswire)
Apr-20-20 06:49AM	Should You Be Concerned About Benitec Biopharma Limited's (NASDAQ:BNTC) Historical Volatility? (Simply Wall St.) +124.78%
Apr-15-20 08:52AM	Benitec Biopharma Announces the Completion of Redomiciliation to the United States (PR Newswire) -10.75%
Apr-14-20 09:28PM	Benitec Biopharma Appoints Edward Smith to the Board of Directors (PR Newswire) -10.31%
Mar-30-20 10:09AM	Benitec Announces Supreme Court of Queensland Approval for Redomicile (PR Newswire)
Mar-26-20 09:44AM	Benitec Announces Results of Scheme Meeting (PR Newswire) +7.60%
Feb-27-20 06:18PM	Is Benitec Biopharma (ASX:BLT) In A Good Position To Deliver On Growth Plans? (Simply Wall St.) +15.11%
Jan-31-20 08:08AM	Appendix 4C: Quarterly Cash Flow Report (PR Newswire) -6.73%
Nov-27-19 08:00AM	ASX/NASDAQ ANNOUNCEMENT: Re-domiciliation to the United States (PR Newswire) -10.17%
Nov-17-19 07:02PM	Some Benitec Biopharma (ASX:BLT) Shareholders Have Taken A Painful 93% Share Price Drop (Simply Wall St.)
Nov-15-19 07:00AM	Public consultation launched on global tailings dam standards (Reuters)
Oct-31-19 08:30AM	Appendix 4C: Quarterly Cash Flow Report (PR Newswire)
Sep-30-19 09:24AM	Benitec Biopharma Limited Announces US$2.25 Million Registered Direct Offering (PR Newswire) -15.24%
Sep-19-19 09:15AM	Benitec Biopharma to present at Ladenburg Thalmann 2019 Healthcare Conference (PR Newswire) -15.85%
Sep-16-19 08:00AM	Benitec Biopharma Provides Update on BB-301 Oculopharyngeal Muscular Dystrophy (OPMD) Program (PR Newswire)
Sep-15-19 09:49PM	Does Market Volatility Impact Benitec Biopharma Limited's (ASX:BLT) Share Price? (Simply Wall St.)
Jul-31-19 08:30AM	ASX/NASDAQ ANNOUNCEMENT Appendix 4C: Quarterly Cash Flow Report (PR Newswire) +28.79%
Jul-11-19 11:34PM	Could The Benitec Biopharma Limited (ASX:BLT) Ownership Structure Tell Us Something Useful? (Simply Wall St.)
Jun-06-19 08:09AM	Update on Oculopharyngeal Muscular Dystrophy Program (PR Newswire) -34.18%
May-08-19 08:01PM	Should Benitec Biopharma Limited (ASX:BLT) Be Your Next Stock Pick? (Simply Wall St.)
Mar-06-19 09:52PM	Introducing Benitec Biopharma, The Stock That Tanked 92% (Simply Wall St.)
Jan-29-19 09:46PM	Have Insiders Been Buying Benitec Biopharma Limited (ASX:BLT) Shares This Year? (Simply Wall St.) +6.87%
Dec-21-18 10:10AM	Benitec Provides Update on BB-401 Cancer Treatment Program (PR Newswire) -20.82%
Nov-23-18 12:01AM	Is Benitec Biopharma Limiteds (ASX:BLT) Balance Sheet A Threat To Its Future? (Simply Wall St.)
Nov-15-18 07:35AM	Detailed Research: Economic Perspectives on Knight-Swift Transportation, Benitec Biopharma, Eastern, Kiniksa Pharmaceuticals, Qualstar, and Nomura Holdings Inc ADR What Drives Growth in Today's Competitive Landscape (GlobeNewswire) +7.01%
Sep-19-18 08:00AM	Benitec Biopharma Announces the Appointment of Gregory R. Reyes, M.D., Ph.D. as Senior Scientific Advisor (PR Newswire)
Jul-14-18 02:02PM	3 Biotech Stocks That Soared This Week: Are They Buys? (Motley Fool)
Jul-10-18 05:15PM	Axovant, Benitec Gain on Licensing Deal for Gene Therapy (Zacks)
08:10AM	Today's Research Reports on Stocks to Watch: Benitec Biopharma and Pfizer (ACCESSWIRE)
07:30AM	New Catalysts Could Send This $3 Medical Device Stock to $9 (ACCESSWIRE)
Jul-09-18 11:04AM	Axovant, Benetic Jump on Agreement to Develop Gene Therapy for MD (TheStreet.com) +51.93%
Jul-08-18 08:59PM	Benitec Announces Global Licensing Agreement for BB-301 for Treatment of Oculopharyngeal Muscular Dystrophy and Broad Platform Collaboration with Axovant (PR Newswire)
May-31-18 08:00AM	Benitec Biopharma reports financial results for the 2018 fiscal third quarter and provides operational update (PR Newswire)
May-15-18 08:00AM	Benitec to present OPMD data at the American Society of Gene and Cell Therapy Meeting (PR Newswire)
May-03-18 08:00AM	Benitec to Host Investor Webinar on the Company's Oculopharyngeal Muscular Dystrophy (OPMD) Program (PR Newswire)
Apr-24-18 08:00AM	ASX/NASDAQ Announcement (PR Newswire)
Mar-05-18 08:00AM	Benitec Biopharma Launches its Phase 2 Oncology Study in Australia (PR Newswire)
Feb-22-18 08:30AM	Benitec Biopharma reports financial results for the 2018 fiscal second quarter and provides operational update (PR Newswire)
Jan-23-18 04:17PM	Federal R&D Tax Credit Received (PR Newswire)
Jan-16-18 08:00AM	Benitec receives U.S. Orphan Drug Designation for BB-301, its ddRNAi therapeutic for the treatment of oculopharyngeal muscular dystrophy (PR Newswire) +9.06%
Nov-27-17 09:30AM	Alkermes Jumps on License Deal With Biogen -- Biotech Movers (TheStreet.com) +6.14%
08:00AM	Benitec Biopharma provides update on OPMD orphan disease program (PR Newswire)
Oct-18-17 07:45AM	U.S. patent granted for Benitec hepatitis B program (PR Newswire) -5.78%
Sep-05-17 02:54PM	Benitec Biopharma Ltd. :BNTC-US: Earnings Analysis: For the six months ended June 30, 2017 : September 5, 2017 (Capital Cube)
Sep-01-17 04:00PM	Benitec Biopharma Ltd. :BNTC-US: Earnings Analysis: 2017 By the Numbers : September 1, 2017 (Capital Cube)

Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firm's proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy and Chronic Hepatitis B. The company was founded in 1995 and is headquartered in Hayward, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BNTC

Benitec Biopharma Inc

Upgrade your FINVIZ experience